Christos C. Zouboulis

Neuruppin, BB, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 506 publications

Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson's Disease.

Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson's Disease.

Journal: Cells

Published: July 22, 2026

Targeting fatty acid synthase inhibitors for the treatment of acne vulgaris: what can we learn from early phase investigations.

Targeting fatty acid synthase inhibitors for the treatment of acne vulgaris: what can we learn from early phase investigations.

Journal: Expert opinion on investigational drugs

Published: July 08, 2026

Emerging synthetic drugs for the management of hidradenitis suppurativa: a comprehensive update.

Emerging synthetic drugs for the management of hidradenitis suppurativa: a comprehensive update.

Journal: Expert opinion on pharmacotherapy

Published: June 24, 2026

Measuring success in HS treatment from the physician's and the patient's perspective.

Measuring success in HS treatment from the physician's and the patient's perspective.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 09, 2026

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.

Journal: Nature medicine

Published: May 28, 2026

Role of Probiotics in Managing Acne Vulgaris: A Systematic Review and Meta-Analysis of Clinical Trials.

Role of Probiotics in Managing Acne Vulgaris: A Systematic Review and Meta-Analysis of Clinical Trials.

Journal: Journal of cutaneous medicine and surgery

Published: May 19, 2026

Pegylated interferon-α-2a in severe Adamantiades-Behçet disease: A series of seven cases.

Pegylated interferon-α-2a in severe Adamantiades-Behçet disease: A series of seven cases.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 29, 2026

Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 25, 2026

Criteria for Hidradenitis Suppurativa Competence Centers.

Criteria for Hidradenitis Suppurativa Competence Centers.

Journal: Dermatology and therapy

Published: March 20, 2026

Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.

Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.

Journal: International journal of dermatology

Published: March 13, 2026

Responsiveness and minimal clinically important difference of the Quality of Life Relevance-Acne questionnaire.

Responsiveness and minimal clinically important difference of the Quality of Life Relevance-Acne questionnaire.

Journal: Dermatology (Basel, Switzerland)

Published: March 12, 2026

Evaluation of multimodal large language models for psoriasis diagnosis, severity grading, and treatment recommendations from clinical photographs: ChatGPT shows superior performance compared to other large language models.

Evaluation of multimodal large language models for psoriasis diagnosis, severity grading, and treatment recommendations from clinical photographs: ChatGPT shows superior performance compared to other large language models.

Journal: Frontiers in medicine

Published: January 19, 2026

Showing 1-12 of 506

Last Updated: 09/26/2026